Dapagliflozin reduces residual proteinuria in patients with inactive lupus nephritis, randomized crossover trial finds
Elevated IFNα identified as a driver of a distinct immunological endotype in Sjögren’s disease, detectable years before diagnosis
Apremilast associated with improved disease activity and favorable safety profile in psoriatic arthritis: Findings from the Italian MAPSI II Study
